Haoxi Health CEO reports 690,800-share stake

Haoxi Health Technology Ltd director and CEO Fan Zhen has filed an initial statement of beneficial ownership.

Accepted by SEC EDGAR 04/02/2026 - 08:47 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Haoxi Health Technology Ltd director and CEO Fan Zhen has filed an initial statement of beneficial ownership. The filing reports direct ownership of 690,800 Class B ordinary shares, par value US$0.0025 each, as of March 18, 2026. The document does not show any new purchases or sales, but establishes Fan Zhen’s existing equity stake in the company.

Insider Trade Summary

Holdings reported, no transactions

Holdings

Insider Fan Zhen

Role CEO

Type	Security	Shares	Price	Value
Holding	Class B ordinary shares, par value US$0.0025 each	--	--	--

Holdings: Class B ordinary shares, par value US$0.0025 each — 690,800 shares (Direct)

Key Figures

Beneficial ownership: 690,800 Class B ordinary shares Par value per share: US$0.0025 per share Form type: Form 3 (initial beneficial ownership)

3 metrics

Beneficial ownership 690,800 Class B ordinary shares Directly held by CEO and director Fan Zhen as of March 18, 2026

Par value per share US$0.0025 per share Class B ordinary shares of Haoxi Health Technology Ltd

Form type Form 3 (initial beneficial ownership) Insider filing by CEO and director Fan Zhen

Key Terms

Class B ordinary shares, par value, beneficial ownership

3 terms

Class B ordinary shares financial

"Class B ordinary shares, par value US$0.0025 each"

Class B ordinary shares are a type of ownership stake in a company that typically come with different voting rights or privileges compared to other share classes. For investors, they represent a way to hold part of the company’s value and influence its decisions, often with fewer voting rights than Class A shares. Understanding these shares helps investors assess their level of control and potential returns within a company.

par value financial

"Class B ordinary shares, par value US$0.0025 each"

Par value is the fixed amount printed on a bond or stock that represents its original value when issued. It’s like the face value of a coin or bill—what the issuer promises to pay back or the starting price of a stock—though it often doesn’t change with market prices. It matters because it helps determine certain financial details, like how much the company will pay back at maturity.

beneficial ownership financial

"initial statement of beneficial ownership"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Haoxi Health (HAO) CEO Fan Zhen report in this Form 3?

Fan Zhen reports existing beneficial ownership of 690,800 Class B ordinary shares of Haoxi Health Technology Ltd. This Form 3 serves as an initial disclosure of the CEO’s equity stake rather than documenting a new stock purchase or sale.

How many Haoxi Health (HAO) shares does CEO Fan Zhen beneficially own?

The filing shows Fan Zhen beneficially owns 690,800 Class B ordinary shares of Haoxi Health Technology Ltd. These shares are held directly and carry a par value of US$0.0025 each, establishing the CEO’s reported equity position in the company.

Is the Haoxi Health (HAO) Form 3 a buy or sell transaction?

This Form 3 does not report a buy or sell transaction. It is an initial statement of beneficial ownership showing that CEO and director Fan Zhen directly holds 690,800 Class B ordinary shares, setting a baseline for future insider transaction reports.

What type of security does Haoxi Health (HAO) list in this Form 3?

The Form 3 lists Class B ordinary shares of Haoxi Health Technology Ltd with a par value of US$0.0025 each. CEO Fan Zhen reports direct beneficial ownership of 690,800 of these Class B ordinary shares as of March 18, 2026.

What is the significance of a Form 3 filing for Haoxi Health (HAO)?

A Form 3 filing provides the market with an insider’s initial beneficial ownership in a company. For Haoxi Health, CEO Fan Zhen’s Form 3 discloses a direct holding of 690,800 Class B ordinary shares, creating a reference point for any future insider trading disclosures.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Fan Zhen

(Last) (First) (Middle)

ROOM 902, UNIT 1, 9TH FLOOR

NO.6A CHAOYANGMENWAI STREET

(Street)

BEIJING BEIJING 100020

(City) (State) (Zip)

CHINA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Haoxi Health Technology Ltd [ HAO ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Class B ordinary shares, par value US$0.0025 each	690,800	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Zhen Fan	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)